MECP2 and hypertensive disorder: Our study reveals for the first time that the increased transcription of Agtr1a and Slc12a2 is associated with their promoter DNA hypomethylation, resulting from coordinated changes in the enrichment of DNMTs, MeCP2, and TETs at their promoters in the PVN in hypertension.